DHG Pharmaceutical JSCSTC:DHG 77 Net Margin % is 26.35% as of Mar. 2026, which is 51% above its 10-year median of 17.47. GuruFocus rates STC:DHG with a GF Score™ of 77/100 and a GF Value™ of ₫113,344.20 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 956 Drug Manufacturers companies, DHG Pharmaceutical JSC ranks better than 84.62% on this metric.
The historical rank and industry rank for DHG Pharmaceutical JSC's Net Margin % or its related term are showing as below:
STC:DHG'
s Net Margin % Range Over the Past 10 Years
Min: 15.81 Med: 17.47 Max: 21.14
Current: 17.97
STC:DHG's Net Margin % is ranked better than 84.62% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs STC:DHG: 17.97
DHG Pharmaceutical JSC (STC:DHG) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
DHG Pharmaceutical JSC Net Margin % Related Terms
DHG Pharmaceutical JSC Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DHG Pharmaceutical JSC's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DHG Pharmaceutical JSC Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DHG Pharmaceutical JSC's Net Margin % distribution charts can be found below:
* The bar in red indicates where DHG Pharmaceutical JSC's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHG Pharmaceutical JSC (STC:DHG) has a Net Margin % of 26.35% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on DHG Pharmaceutical JSC and its competitors. This is 51% above median its historical median of 17.47. Over the past decade, DHG Pharmaceutical JSC's Net Margin % has ranged from 15.81 to 21.14. According to the industry distribution chart, DHG Pharmaceutical JSC ranks #147 out of 956 companies in the Drug Manufacturers industry, placing it in the top 15.4%.
Is DHG Pharmaceutical JSC's Net Margin % too high?
DHG Pharmaceutical JSC's current Net Margin % of 26.35% is 51% above median its 10-year median of 17.47. Over the past 10 years, this metric has ranged from a low of 15.81 to a high of 21.14. The Drug Manufacturers industry median Net Margin % is 5.56. DHG Pharmaceutical JSC's value of 26.35% is 373.9% above this industry median. Based on the distribution chart, DHG Pharmaceutical JSC ranks #147 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, DHG Pharmaceutical JSC has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DHG Pharmaceutical JSC's Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, DHG Pharmaceutical JSC ranks #147 out of 956 companies for Net Margin %. This places DHG Pharmaceutical JSC in the top 15% of its industry — outperforming the majority of peers. The industry median Net Margin % is 5.56. DHG Pharmaceutical JSC's value of 26.35% is 373.9% above this benchmark. Historically, DHG Pharmaceutical JSC's own Net Margin % has ranged from 15.81 to 21.14 over the past decade. While the company's 10-year median is 17.47 vs. the industry median of 5.56, DHG Pharmaceutical JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DHG Pharmaceutical JSC's current Net Margin % of 26.35% is 373.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on DHG Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DHG Pharmaceutical JSC's current Net Margin % is 26.35%, which is 51% above median its own 10-year median of 17.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DHG Pharmaceutical JSC stock overvalued right now?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC (STC:DHG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫113,344.20, compared to a current price of ₫94,700.00 — trading 16.4% below its estimated fair value. The current Net Margin % is 26.35%, which is 51% above median its 10-year median of 17.47 and 373.9% above the Drug Manufacturers industry median of 5.56. DHG Pharmaceutical JSC's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For DHG Pharmaceutical JSC (STC:DHG), the current Net Margin % is 26.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DHG Pharmaceutical JSC (STC:DHG) Overvalued in 2026?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC stock appears to be undervalued.
The current stock price of ₫94,700.00 is trading 16.4% below its estimated GF Value™ of ₫113,344.20.
GuruFocus considers DHG Pharmaceutical JSC to be Modestly Undervalued.
Key valuation signals for STC:DHG:
Net Margin %: 26.35% (51% above median its 10-year median of 17.47)
GF Value™: ₫113,344.20 vs. price of ₫94,700.00 (16.4% below fair value)
Industry Position: 373.9% above the Drug Manufacturers median (#147 of 956)
No single metric tells the full story. See the STC:DHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotics, antifungals, and antiparasitics; analgesics and antipyretics; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
77GF Score
Get the complete analysis for STC:DHG
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DHG has been successfully added to your 
